Alvydas Mikulskis
Senior Director, Clinical Biomarkers & Imaging at Vertex Pharmaceuticals
Alvydas Mikulskis is a strong leader and manager with extensive experience in developing and supporting bioanalytical and biomarker assays for biologics and small molecule drugs across various stages of clinical development.
He is a technical expert in immunoassay technology platforms, with a focus on precision and compliance in preclinical and clinical trials, including patient stratification and enrichment in Phase III trials.
Alvydas Mikulskis is a recognized expert in Design of Experiments (DOE), with certifications in Six Sigma Green Belt, and a history of successful patents, publications, and industry committee involvement.
His leadership style emphasizes collaboration, innovation, and a results-oriented approach, with a strong emphasis on high-quality outcomes and problem-solving abilities.
With a diverse educational background in biology and molecular pathogenesis, Alvydas Mikulskis has held key roles in prestigious organizations like Vertex Pharmaceuticals, Takeda, Biogen, and PerkinElmer Life & Analytical Sciences, contributing significantly to biomarker and imaging advancements in drug development.
People also Viewed
Mutual Connections
People also Viewed